The U.S. Food and Drug Administration (FDA) has announced that the Botanical Safety Consortium (BSC) has formally been convened. This milestone is the result of a Memorandum of Understanding (MOU) that was recently signed between the FDA, the National Institutes of Health’s National Institute of Environmental Health Sciences, and the Health and Environmental Sciences Institute (HESI). This MOU establishes the framework for the BSC.
The BSC was originally announced in the FDA’s February 2019 statement on the agency’s new efforts to strengthen regulation of dietary supplements through modernization and reform. The Consortium’s mission is to provide a forum for scientists from government, academia, consumer health groups, industry, and non-profit organizations to work collaboratively to generate a sound scientific basis for integrating existing safety data and the latest toxicology tools to evaluate botanical safety in dietary supplements. With the execution of the MOU, specific guidelines for membership and participation in the BSC will be established by early 2020.
HESI, a non-profit 501(c)(3) charitable scientific organization, will serve as the convener and facilitator for the BSC.
As the COVID-19 pandemic continues, a new report warns that further outbreaks will emerge unless governments take active measures to prevent other zoonotic diseases from crossing into the human population and sets out recommendations to prevent future pandemics.
The U.S. Food and Drug Administration (FDA) has announced the publication of the manuscript “Allergen Removal and Transfer with Wiping and Cleaning Methods Used in Retail and Food Service Establishments.”
The FDA, along with the CDC and state and local partners, continue to investigate a multistate outbreak of Cyclospora infections potentially linked to Aldi, Hy-Vee, and Jewel-Osco grocery store brand “garden salads” containing iceberg lettuce, red cabbage, and carrots.
Eighty-five million U.S. consumers managing food allergies spend more than $19 billion annually on specialty food products to avoid allergic reactions or other health consequences—paying 5% more per month than the average consumer—according to new research released from FARE.
The U.S. Food and Drug Administration (FDA) has announced improvements to the functionality and appearance of two types of export certificates issued for human food products exported from the United States.
Chicago Section IFT Annual Suppliers’ Symposium & Expo
Rosemont, Illinois, United States